1Department of Neurology, Kohnodai Hospital.
This study explores lymphocytapheresis as a novel treatment for active multiple sclerosis (MS), an autoimmune CNS disease. Preliminary results show immediate improvement in some MS patients, suggesting a new immunotherapy approach.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: